PL377462A1 - Pochodna oligosacharydowa - Google Patents

Pochodna oligosacharydowa

Info

Publication number
PL377462A1
PL377462A1 PL377462A PL37746204A PL377462A1 PL 377462 A1 PL377462 A1 PL 377462A1 PL 377462 A PL377462 A PL 377462A PL 37746204 A PL37746204 A PL 37746204A PL 377462 A1 PL377462 A1 PL 377462A1
Authority
PL
Poland
Prior art keywords
groups
pharmacologically acceptable
oligosaccharide derivative
group
chem
Prior art date
Application number
PL377462A
Other languages
English (en)
Inventor
Takeshi Honda
Akira Okuno
Masanori Izumi
Xiaoliu Li
Original Assignee
Sankyo Company, Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Company, Limited filed Critical Sankyo Company, Limited
Publication of PL377462A1 publication Critical patent/PL377462A1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/203—Monocyclic carbocyclic rings other than cyclohexane rings; Bicyclic carbocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/02—Heterocyclic radicals containing only nitrogen as ring hetero atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrane Compounds (AREA)
PL377462A 2003-01-30 2004-01-29 Pochodna oligosacharydowa PL377462A1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2003022800 2003-01-30

Publications (1)

Publication Number Publication Date
PL377462A1 true PL377462A1 (pl) 2006-02-06

Family

ID=32820702

Family Applications (1)

Application Number Title Priority Date Filing Date
PL377462A PL377462A1 (pl) 2003-01-30 2004-01-29 Pochodna oligosacharydowa

Country Status (21)

Country Link
US (2) US7361744B2 (pl)
EP (1) EP1589023B1 (pl)
KR (1) KR101050981B1 (pl)
CN (2) CN100360548C (pl)
AT (1) ATE478884T1 (pl)
AU (1) AU2004207726B2 (pl)
BR (1) BRPI0406990A (pl)
CA (1) CA2514931A1 (pl)
DE (1) DE602004028799D1 (pl)
DK (1) DK1589023T3 (pl)
ES (1) ES2349736T3 (pl)
IL (1) IL169577A (pl)
MX (1) MXPA05008190A (pl)
NO (1) NO20053997L (pl)
NZ (1) NZ541455A (pl)
PL (1) PL377462A1 (pl)
PT (1) PT1589023E (pl)
RU (1) RU2290408C2 (pl)
TW (1) TWI318202B (pl)
WO (1) WO2004067542A1 (pl)
ZA (1) ZA200506075B (pl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200608967A (en) * 2004-07-29 2006-03-16 Sankyo Co Pharmaceutical compositions containing with diabetic agent
TW200612968A (en) * 2004-07-29 2006-05-01 Sankyo Co Oligosaccharide derivatives containing with heterocycle
TW200735880A (en) * 2006-01-27 2007-10-01 Sankyo Co Medicinal compositions for preventing or treating heart failure
GB0614947D0 (en) * 2006-07-27 2006-09-06 Isis Innovation Epitope reduction therapy

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE89563T1 (de) * 1986-08-13 1993-06-15 Hoechst Ag Oxiran-pseudooligosaccharide, verfahren zu deren herstellung, deren verwendung und pharmazeutische praeparate.
US5318986A (en) * 1989-10-19 1994-06-07 Mitsui Norin Co., Ltd. Method of inhibiting the activity of α-amylase
US5783568A (en) * 1994-06-10 1998-07-21 Sugen, Inc. Methods for treating cancer and other cell proliferative diseases
FR2751334B1 (fr) * 1996-07-19 1998-10-16 Sanofi Sa Polysaccharides synthetiques, procede pour leur preparation et compositions pharmaceutiques les contenant
JP4643775B2 (ja) * 1999-01-13 2011-03-02 日本食品化工株式会社 香気成分生成阻害剤
JP3909735B2 (ja) * 1999-02-22 2007-04-25 キッコーマン株式会社 マルトオリゴ糖誘導体及びその用途
AU3499400A (en) 1999-02-23 2000-09-14 Ips Corporation Low voc (volatile organic compounds), dimethyl-2-piperidone solvent-based, pvc and cpvc pipe and component adhesives and primers containing minimal or no tetrahydrofuran
ATE278701T1 (de) * 2000-06-06 2004-10-15 Kikkoman Corp Malto-oligosaccharide und deren verwendung

Also Published As

Publication number Publication date
CA2514931A1 (en) 2004-08-12
ZA200506075B (en) 2006-05-31
EP1589023A4 (en) 2008-12-10
DE602004028799D1 (en) 2010-10-07
EP1589023A1 (en) 2005-10-26
IL169577A0 (en) 2007-07-04
KR101050981B1 (ko) 2011-07-21
NO20053997D0 (no) 2005-08-29
TW200502204A (en) 2005-01-16
BRPI0406990A (pt) 2006-01-10
CN101367851A (zh) 2009-02-18
AU2004207726A1 (en) 2004-08-12
DK1589023T3 (da) 2010-12-13
NO20053997L (no) 2005-10-28
WO2004067542A1 (ja) 2004-08-12
MXPA05008190A (es) 2006-02-17
PT1589023E (pt) 2010-10-29
IL169577A (en) 2010-06-16
US20060025350A1 (en) 2006-02-02
EP1589023B1 (en) 2010-08-25
RU2005124286A (ru) 2006-01-27
US7632930B2 (en) 2009-12-15
NZ541455A (en) 2007-08-31
US20080194495A1 (en) 2008-08-14
KR20050094465A (ko) 2005-09-27
AU2004207726B2 (en) 2007-03-15
ATE478884T1 (de) 2010-09-15
CN100360548C (zh) 2008-01-09
US7361744B2 (en) 2008-04-22
TWI318202B (en) 2009-12-11
HK1077070A1 (en) 2006-02-03
ES2349736T3 (es) 2011-01-11
CN1768073A (zh) 2006-05-03
RU2290408C2 (ru) 2006-12-27

Similar Documents

Publication Publication Date Title
DK1213296T3 (da) Glucopyranosyloxpyrazolderivater, lægemidler indeholdende samme samt mellemprodukter til fremstilling heraf
IL166748A0 (en) Pyrazole derivative medicinal composition containing the same medicinal use thereof and intermediatefor production thereof
ATE260263T1 (de) Heteroaromatische bizyklische verbindungen mit antikrebswirkung
NO20054852L (no) GFAT inhibitorer
EP1736467A4 (en) NEW SULFONIC ACID AMID DERIVATIVE
AU4396899A (en) Remedies for diabetes
NO20052074L (no) Substituerte benzoksazinoner og anvendelser derav.
EP1634874A4 (en) imidazolidine
ATE503746T1 (de) Neue imidazolidinderivate
EP1902716A4 (en) PROPHYLACTIC AND / OR THERAPEUTIC AGENT FOR MOTOR TROUBLESHOOTING
TWI319316B (en) Aminoalcohol derivatives and pharmaceutical compositions containing the same
EP1152004A4 (en) PHOSPHONIC ACID DERIVATIVES HAVING CARBOXYPEPTIDASE B INHIBITOR ACTIVITY
EP1627635A3 (en) Benzothiazolium compounds for use in methods of inhibiting NO production and TNF alpha and treating coronaviral infection
PL377462A1 (pl) Pochodna oligosacharydowa
NO323556B1 (no) Forbindelser, farmasoytiske preparater som omfatter forbindelsene, og anvendelse av forbindelsene ved fremstilling av antibakterielle medikamenter.
EP1914229A4 (en) NOVEL CERCOSPORAMIDE DERIVATIVES
EP1254907A4 (en) Pyrrolopyridazine CONNECTIONS
EP1493441A4 (en) THERAPEUTIC AGENT FOR FOOD DISEASES IN THE STOMACH
DE60238847D1 (de) Pyrimidinderivate enthaltendes medikament
MX2008002753A (es) Derivados de piridazinona utilizados para el tratamiento de dolor.
TH62392A (th) อนุพันธ์ควิโนลีนและไพริดีนชนิดใหม่
PL342826A1 (en) Derivatives of cycloalkenes, their production and application

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)